If I may then, Mr. Chair, very quickly, as was pointed out on transparency, we're looking at what we can do to accelerate and go beyond the recommendations of the Auditor General.
We're looking at issues like the labels and how readable they are, plain language information for Canadians, and the product monographs, which are quite large and sometimes difficult for physicians to digest quickly—so easier and more accessible summaries.
We're taking a look at a range of things beyond what the Auditor General pointed out.